APA
Ennishi D., Healy S., Bashashati A., Saberi S., Hother C., Mottok A., Chan F. C., Chong L., Abraham L., Kridel R., Boyle M., Meissner B., Aoki T., Takata K., Woolcock B. W., Viganò E., Gold M., Molday L. L., Molday R. S., Telenius A., Li M. Y., Wretham N., Dos Santos N., Wong M., Viller N. N., Uger R. A., Duns G., Baticados A., Madero A., Bristow B. N., Farinha P., Slack G. W., Ben-Neriah S., Lai D., Zhang A. W., Salehi S., Shulha H. P., Chiu D. S., Mostafavi S., Gerrie A. S., Huang D. W., Rushton C., Villa D., Sehn L. H., Savage K. J., Mungall A. J., Weng A. P., Bally M. B., Morin R. D., Cohen Freue G. V., Staudt L. M., Connors J. M., Marra M. A., Shah S. P., Gascoyne R. D., Scott D. W. & Steidl C. (20200722). TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. : Nature medicine.
Chicago
Ennishi Daisuke, Healy Shannon, Bashashati Ali, Saberi Saeed, Hother Christoffer, Mottok Anja, Chan Fong Chun, Chong Lauren, Abraham Libin, Kridel Robert, Boyle Merrill, Meissner Barbara, Aoki Tomohiro, Takata Katsuyoshi, Woolcock Bruce W, Viganò Elena, Gold Michael, Molday Laurie L, Molday Robert S, Telenius Adele, Li Michael Y, Wretham Nicole, Dos Santos Nancy, Wong Mark, Viller Natasja N, Uger Robert A, Duns Gerben, Baticados Abigail, Madero Angel, Bristow Brianna N, Farinha Pedro, Slack Graham W, Ben-Neriah Susana, Lai Daniel, Zhang Allen W, Salehi Sohrab, Shulha Hennady P, Chiu Derek S, Mostafavi Sara, Gerrie Alina S, Huang Da Wei, Rushton Christopher, Villa Diego, Sehn Laurie H, Savage Kerry J, Mungall Andrew J, Weng Andrew P, Bally Marcel B, Morin Ryan D, Cohen Freue Gabriela V, Staudt Louis M, Connors Joseph M, Marra Marco A, Shah Sohrab P, Gascoyne Randy D, Scott David W and Steidl Christian. 20200722. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. : Nature medicine.
Harvard
Ennishi D., Healy S., Bashashati A., Saberi S., Hother C., Mottok A., Chan F. C., Chong L., Abraham L., Kridel R., Boyle M., Meissner B., Aoki T., Takata K., Woolcock B. W., Viganò E., Gold M., Molday L. L., Molday R. S., Telenius A., Li M. Y., Wretham N., Dos Santos N., Wong M., Viller N. N., Uger R. A., Duns G., Baticados A., Madero A., Bristow B. N., Farinha P., Slack G. W., Ben-Neriah S., Lai D., Zhang A. W., Salehi S., Shulha H. P., Chiu D. S., Mostafavi S., Gerrie A. S., Huang D. W., Rushton C., Villa D., Sehn L. H., Savage K. J., Mungall A. J., Weng A. P., Bally M. B., Morin R. D., Cohen Freue G. V., Staudt L. M., Connors J. M., Marra M. A., Shah S. P., Gascoyne R. D., Scott D. W. and Steidl C. (20200722). TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. : Nature medicine.
MLA
Ennishi Daisuke, Healy Shannon, Bashashati Ali, Saberi Saeed, Hother Christoffer, Mottok Anja, Chan Fong Chun, Chong Lauren, Abraham Libin, Kridel Robert, Boyle Merrill, Meissner Barbara, Aoki Tomohiro, Takata Katsuyoshi, Woolcock Bruce W, Viganò Elena, Gold Michael, Molday Laurie L, Molday Robert S, Telenius Adele, Li Michael Y, Wretham Nicole, Dos Santos Nancy, Wong Mark, Viller Natasja N, Uger Robert A, Duns Gerben, Baticados Abigail, Madero Angel, Bristow Brianna N, Farinha Pedro, Slack Graham W, Ben-Neriah Susana, Lai Daniel, Zhang Allen W, Salehi Sohrab, Shulha Hennady P, Chiu Derek S, Mostafavi Sara, Gerrie Alina S, Huang Da Wei, Rushton Christopher, Villa Diego, Sehn Laurie H, Savage Kerry J, Mungall Andrew J, Weng Andrew P, Bally Marcel B, Morin Ryan D, Cohen Freue Gabriela V, Staudt Louis M, Connors Joseph M, Marra Marco A, Shah Sohrab P, Gascoyne Randy D, Scott David W and Steidl Christian. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. : Nature medicine. 20200722.